Protein-based therapeutics represent a rapidly growing segment of approved disease
treatments. Successful intracellular delivery of proteins is an important precondition for …

Biomolecules have many properties that make them promising for intracellular therapeutic
applications, but delivery remains a key challenge because large biomolecules cannot …

Persistent infection with high-risk human papillomavirus (HPV) is widely recognized as the
primary cause of cervical and other malignant cancers. There are six licensed prophylactic …

The potential of nucleic acid therapeutics to treat diseases by targeting specific cells has
resulted in its increasing number of uses in clinical settings. However, the major challenge is …

The high risk human papillomavirus (HPV) types 16 and 18 are globally linked to> 50% and
20% of all cervical cancers, respectively. The HPV E7 oncoprotein was determined as a …

The successful intracellular delivery of biologically active proteins and peptides plays an
important role for therapeutic applications. Indeed, protein/peptide delivery could overcome …

Fluorescent proteins (FPs) are powerful and fundamental tools in bio-analytical research,
ranging from tracking biological molecules to monitoring dynamic processes in living cells …

The incidence of high-risk Human Papillomavirus (HR-HPV)-driven head and neck
squamous cell carcinoma (HNSCC) is on the rise globally. HR-HPV-driven HNSCC displays …

Objectives Developing an effective HIV vaccine that stimulates the humoral and cellular
immune responses is still challenging because of the diversity of HIV-1 virus, polymorphism …

Although groundbreaking biotechnological techniques such as gene editing have
significantly progressed, the effective and targeted transport of therapeutic agents into host …